Tag: pharmaceuticals
-
Genocea, Harvard, Dana-Farber to Partner on Melanoma
3 March 2014. Genocea Biosciences, a biotechnology company in Cambridge, Massachusetts, with Harvard Medical School and Dana-Farber Cancer Research Institute, are testing the company’s vaccine discovery platform to help target therapies for melanoma, an aggressive form of skin cancer. The collaboration is funded by Ludwig Institute for Cancer Research, but financial aspects of the partnership…
-
Asthma Drug Helps Desensitize Multiple Food Allergies
28 February 2014. Medical researchers at Stanford University in California and Johns Hopkins University in Baltimore found in an early-stage clinical trial that an asthma drug dramatically reduces the time needed for patients to lower their sensitivity to several food allergies at one time. The team led by Stanford’s Kari Nadeau and Johns Hopkins’s Robert Hamilton…
-
Clinical Trial Testing New, Current Breast Cancer Drugs
27 February 2014. The global pharmaceutical company Eisai Inc. is starting a late-stage clinical trial of its drug eribulin mesylate to treat certain types of recurring or metastatic breast cancer, compared to the current chemotherapy drug paclitaxel. The trial is a joint project of Eisai’s U.S. subsidiary, in Woodcliff Lakes, New Jersey, and Academic and…
-
Zoetis Funding Cat Health Foundation Research Awards
26 February 2014. Zoetis Inc., an animal health company in Florham Park, New Jersey, is funding grants to researchers for studies into pain, joint health, and kidney disorders in cats. Grants totaling $100,000 will be made available through the Winn Feline Foundation, with a due date for proposals of 21 April 2014. The company says…
-
Walgreens, UCSF Partner on Patient Medication Management
26 February 2014. The Walgreens pharmacy chain and University of California in San Francisco are collaborating on new pharmacy services that help patients manage medications to improve their overall health. The company and university are testing this new retail model in a Walgreens store located near the UCSF campus, but financial aspects of the arrangement…
-
Fox Foundation Proposes Improving Trial Patient Recruitment
20 February 2014. Research managers at the Michael J. Fox Foundation for Parkinson’s Research in New York propose improvements in practices for recruiting patients for clinical trials to reduce obstacles that delay or even prevent trials from happening. The team led by Fox Foundation vice president Sohini Chowdhury presents its ideas in this month’s issue…
-
New Clinical Trial Testing Drug for Huntington’s Disease
19 February 2014. Omeros Corporation in Seattle began an intermediate-stage clinical trial testing its compound code-named OMS824 to treat symptoms of Huntington’s disease. The company says it’s administering the first doses in the trial, which is expected to enroll 120 patients. Huntington disease is an inherited disorder in which nerve cells in certain parts of…
-
FDA Speeds Lymph Node Detector Review for Head/Neck Cancer
18 February 2014. Navidea Biopharmaceuticals Inc. in Dublin, Ohio, says the U.S. Food and Drug Administration is giving the company’s diagnostic agent Lymphoseek priority review for detecting the spread of head and neck cancers to lymph nodes. FDA granted the accelerated review as part of its acceptance of Navidea’s supplemental new drug application to expand…
-
Start-Up Developing Gene Therapies Lands $45M in Early Funds
12 February 2014. Voyager Therapeutics, a new start-up in Cambridge, Massachusetts creating gene therapies for disorders of the central nervous system, gained $45 million in first-round financing. Third Rock Ventures, a venture capital company specializing in life science enterprises, provided the funds for the company founded by researchers at University of Massachusetts Medical School, University…
-
Cancer Drugs Shown With Potential Against HIV-Related Fungus
11 February 2014. Medical researchers at University of Rochester in New York found two drugs treating breast cancer have properties that point to their potential as a treatment for Cryptococcus, a fungus causing meningitis in people with HIV/AIDS. The team led by Rochester’s Damian Krysan, with colleagues from Temple and Duke universities and University of…